ClinConnect ClinConnect Logo
Search / Trial NCT02023060

Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

Launched by SHEBA MEDICAL CENTER · Dec 22, 2013

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to understand how patients feel and function after undergoing a procedure called transcatheter heart valve replacement. This procedure is often used for people with aortic stenosis, a condition where the heart's aortic valve becomes narrowed and makes it harder for blood to flow. The researchers want to see how patients' characteristics and health outcomes change over time after the surgery.

To participate in this trial, you need to be someone who is selected for this heart valve replacement and willing to give your consent to join the study. The trial is open to both men and women between the ages of 65 and 74. If you decide to join, you’ll be monitored to see how the procedure affects your quality of life and overall health. It’s important to know that pregnant or breastfeeding women cannot participate, and individuals who cannot provide consent will also be excluded. This study is currently recruiting participants, so if you're interested, it could be a good opportunity to contribute to important research while receiving care for your condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subject selected for transcatheter heart valve replacement
  • 2. Signed informed consent to participate in the study
  • Exclusion Criteria:
  • 1. Inability to sign written informed consent.
  • 2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).

About Sheba Medical Center

Sheba Medical Center, located in Israel, is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, Sheba Medical Center leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and developing novel therapeutic interventions. The center's collaborative environment fosters partnerships with global research organizations, enhancing its ability to contribute to the scientific community and drive medical advancements across various fields. With a strong focus on patient safety and ethical standards, Sheba Medical Center is dedicated to translating research findings into practical applications that benefit patients worldwide.

Locations

Jerusalem, , Israel

Tel Aviv, , Israel

Ramat Gan, , Israel

Petah Tikva, , Israel

Jerusalem, , Israel

Patients applied

0 patients applied

Trial Officials

Israel Barbash, MD

Study Chair

Sheba Medical Center, Tel Hashomer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials